Published in J Invest Dermatol on March 01, 1981
Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol (1982) 1.76
Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med (2005) 1.39
Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol (1985) 1.29
Light, including ultraviolet. J Autoimmun (2009) 1.28
Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc Natl Acad Sci U S A (1983) 1.18
Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect Immun (1986) 1.13
The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology (1992) 1.09
Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med (1982) 1.06
UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett (2007) 1.05
Langerhans cells in various benign and malignant pigment-cell lesions of the skin. Arch Dermatol Res (1984) 0.98
Carcinogen-induced depletion of cutaneous Langerhans cells. Br J Cancer (1985) 0.96
Systemic suppression of contact hypersensitivity by UVB radiation is unrelated to the UVB-induced alterations in the morphology and number of Langerhans cells. Immunology (1984) 0.93
Significant changes in epidermal Langerhans cells of guinea-pigs infested with ticks (Dermacentor andersoni). Immunology (1984) 0.93
Photoimmunology--illuminating the immune system through photobiology. Semin Immunopathol (2007) 0.91
Epidermal Langerhans cells are not required for UV-induced immunosuppression. J Immunol (2009) 0.91
Tumour promoters but not initiators deplete Langerhans cells from murine epidermis. Br J Cancer (1987) 0.90
Alterations in epidermal handling of HSV-1 antigens in vitro induced by in vivo exposure to UV-B light. Immunology (1986) 0.90
Epidermal Langerhans cell number and morphology during oral retinoid treatment. Arch Dermatol Res (1982) 0.88
Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene. Immunology (1987) 0.88
Ultrastructural studies bearing on the mechanism of UVB-impaired induction of contact hypersensitivity to DNCB in man. Clin Exp Immunol (1993) 0.87
Effect of a single UVB or PUVA exposure on immediate and delayed skin hypersensitivity reactions in humans. Correlation to erythemal response and Langerhans cell depletion. Arch Dermatol Res (1983) 0.86
Risk assessment for the harmful effects of UVB radiation on the immunological resistance to infectious diseases. Environ Health Perspect (1998) 0.85
Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes. Immunology (1999) 0.85
Quantification of quantum dot murine skin penetration with UVR barrier impairment. Nanotoxicology (2013) 0.83
Effect of orally administered aromatic retinoid on murine Langerhans cells. Arch Dermatol Res (1987) 0.82
Ultrastructural morphometry of epidermal Langerhans' cells: introduction of a simple method for a comprehensive quantitative analysis of the cells. Arch Dermatol Res (1986) 0.82
Langerhans cells and melanocytes share similar morphologic features under in vivo reflectance confocal microscopy: a challenge for melanoma diagnosis. J Am Acad Dermatol (2011) 0.82
Effects of ultraviolet irradiation on epidermal Langerhans cells in guinea-pigs. Immunology (1984) 0.81
Increased Langerhans cell accumulation after mycobacterial stimuli. Histopathology (2007) 0.80
Antigenic stimulation during ultraviolet therapy in man does not result in immunological tolerance. Clin Exp Immunol (1989) 0.78
Effect of UVB radiation on the biosynthesis of HLA-DR antigens. Arch Dermatol Res (1987) 0.78
Human in vitro skin organ culture as a model system for evaluating DNA repair. J Dermatol Sci (2014) 0.77
Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposure. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.77
Studies on the effects of a high dose UVA-1 radiation therapy on surface markers and function of epidermal Langerhans cells. Arch Dermatol Res (1993) 0.76
Contact sensitization through Langerhans cell-deficient plantar skin. Arch Dermatol Res (1987) 0.75
A novel synthetic vitamin-A-like compound (a polyprenoic acid derivative: E-5166) inhibits UVB-stimulated epidermal ornithine decarboxylase activity. Arch Dermatol Res (1986) 0.75
A semiquantitative light and electron microscopic analysis of histopathologic changes in photochemotherapy-induced freckles. Arch Dermatol Res (1984) 0.75
ATPase, antigens detected by monoclonal antibodies, ultrastructural characters: which is the best marker for Langerhans cells? Arch Dermatol Res (1983) 0.75
Effect of UV-irradiation on immunological and histochemical markers of Langerhans cells in normal appearing skin of psoriatic patients. Arch Dermatol Res (1982) 0.75
Stimulation of the recruitment of epidermal Langerhans cells by splenopentin. Arch Dermatol Res (1990) 0.75
The effect of cryo-treatment on epidermal Langerhans cells and immune function in mice. Arch Dermatol Res (1994) 0.75
Reduced antigen-presenting function of human Epstein-Barr virus (EBV)-B cells and monocytes after UVB radiation is accompanied by decreased expression of B7, intercellular adhesion molecule-1 (ICAM-1) and LFA-3. Clin Exp Immunol (1995) 0.75
Effect of oral methoxsalen photochemotherapy on human Langerhans cell number. Dose-response and time-sequence studies. Arch Dermatol Res (1982) 0.75
Endonasal phototherapy significantly alleviates symptoms of allergic rhinitis, but has a limited impact on the nasal mucosal immune cells. Eur Arch Otorhinolaryngol (2010) 0.75
"Multi Light and Drugs": a new technique to treat face photoaging. Comparative study with photorejuvenation. Lasers Med Sci (2007) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
A physical map of the human genome. Nature (2001) 12.39
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med (2001) 7.86
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med (1987) 5.64
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med (1992) 5.03
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. N Engl J Med (1993) 4.88
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med (1988) 4.79
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol (1978) 4.55
Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med (2000) 4.43
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell (1994) 4.04
Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation (2003) 3.86
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods (1996) 3.80
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med (1986) 3.74
Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med (2001) 3.74
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol (1987) 3.41
Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol (1995) 3.34
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Epidermal Langerhans cells bear Fc and C3 receptors. Nature (1977) 3.21
Diagnostic accuracy of dermoscopy. Lancet Oncol (2002) 3.14
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85
Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol (2000) 2.75
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol (1989) 2.63
Origin and function of epidermal Langerhans cells. Immunol Rev (1980) 2.54
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47
Impact of landscape management on the genetic structure of red squirrel populations. Science (2001) 2.34
Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA (2000) 2.29
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation (2001) 2.28
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol (2000) 2.24
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21
Expression of Thy-1 antigen by murine epidermal cells. J Invest Dermatol (1983) 2.20
Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol (1999) 2.19
Dendritic cells as vectors for therapy. Cell (2001) 2.18
Phototesting and dosimetry for photochemotherapy. Br J Dermatol (1977) 2.17
Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J Immunol (1988) 2.17
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest (1993) 2.16
Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Br J Dermatol (2007) 2.15
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci (1993) 2.15
Identification of a T3-associated gamma delta T cell receptor on Thy-1+ dendritic epidermal Cell lines. Science (1987) 2.12
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol (1995) 2.11
Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol (1993) 2.10
Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci U S A (1991) 2.06
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
The effect of aortic valve replacement on survival. Circulation (1982) 2.03
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med (1985) 1.93
Detection of Ia antigens on Langerhans cells in guinea pig skin. J Immunol (1978) 1.90
A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J Immunol (1984) 1.90
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol (1987) 1.90
Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med (1999) 1.89
Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol (1976) 1.89
Epidermal cells adhere preferentially to type IV (basement membrane) collagen. J Cell Biol (1979) 1.86
Ecstasy pill testing: harm minimization gone too far? Addiction (2001) 1.85
Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med (1994) 1.85
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol (1998) 1.82
The fine structure of the Langerhans cell granule. J Cell Biol (1967) 1.79
Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med (1992) 1.77
Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol (1999) 1.77
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
HIV-related skin diseases. Lancet (1996) 1.76
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. J Invest Dermatol (1978) 1.71
Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy (2003) 1.69
The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin Immunopathol (1992) 1.68
Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet (2000) 1.68
The langerhans cell. Curr Probl Dermatol (1972) 1.67
Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol (1988) 1.62
Methadone maintenance and tuberculosis treatment. BMJ (1996) 1.61
Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. J Immunol (1981) 1.60
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol (1997) 1.60